Home
Avoro Capital Advisors reported a 3.15% stake in MoonLake Immunotherapeutics MLTX · 2,000,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.15%
- Last report
- 6.5% · filed 25/08/14
- Shares held
- 2,000,000 sh
- Class
- Class A Ordinary Shares, par value $0.0001 per share
- Holder
- Avoro Capital Advisors
- Event date
- 25/09/30
- Filed
- 25/11/14
3.15% stake · below 5%
- Stake
- 3.15%
- Last report
- 6.5%
- Since last report
- −3.4pp
MoonLake Immunotherapeutics trades, last 26 weeks
What else happened in MoonLake Immunotherapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Avoro Capital Advisors's other 5% stake reports
- Avoro Capital Advisors
5% stakeHemab Therapeutics Holdings
5% stakeHemab Therapeutics Holdings
COAG
7.06% stake
3,298,236 sh
7.06% stake
Filed 08/14
- Avoro Capital Advisors
5% stakeArrowhead Pharmaceuticals
5% stakeArrowhead Pharmaceuticals
ARWR
9.64% stake
13,823,383 sh
9.64% stake
Filed 08/14
- Avoro Capital Advisors
5% stakeAvalo Therapeutics
5% stakeAvalo Therapeutics
AVTX
4.44% stake
2,333,333 sh
4.44% stake
Filed 08/14
- Avoro Capital Advisors
5% stakeScribe Therapeutics
5% stakeScribe Therapeutics
SCTX
16.37% stake
3,088,888 sh
16.37% stake
Filed 07/30
- Avoro Capital Advisors
5% stakeDamora Therapeutics
5% stakeDamora Therapeutics
DMRA
6.27% stake
3,783,000 sh
6.27% stake
Filed 05/15
